Nervgen Pharma Corp.NGEN
Price (close)
$2.02
Market cap
$217.2M
P/E
—
Revenue (FY)
—
Net income
-$44.1M
Dividend yield
—
1-year total return
-16.9%
Net margin
—
Revenue growth
—
Debt / equity
—
What Nervgen Pharma Corp. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net income | — | -$24.3M | -$44.1M |
More on NGEN.
- Nervgen Pharma Corp. summary
- Nervgen Pharma Corp. financial statements
- Nervgen Pharma Corp. key metrics
- Nervgen Pharma Corp. health scores and style box
- Nervgen Pharma Corp. earnings
- Nervgen Pharma Corp. dividends
- Nervgen Pharma Corp. valuation
- Nervgen Pharma Corp. ownership and insiders
- Nervgen Pharma Corp. peers
Figures from Nervgen Pharma Corp.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.